Table 3.
List of eRNAs involved in inflammatory effects in tumors.
| Cancer | Affected cell | Enhancer or SE | eRNA | Regulated gene | Mechanism | Function | Reference |
|---|---|---|---|---|---|---|---|
| Pre-B ALL | Pre-B ALL cell GREAT |
No | eRNA | ICOSLG, IRF4, MSA1 | Down-regulate migration, proliferation and apoptosis gene | Promotes malignant progression | (151) |
| Pre-B ALL | Pre-B ALL cell | CD19+/CD20+ spectrum SE | eRNA | ETV6-RUNX1 | Interference with B-cell signaling and adhesion signaling | Disrupt normal B lymphopoiesis | (152) |
| T ALL | Leukemia cell | ARID5B enhancer | ARIEL eRNA | ARID5B MYC |
Recruition of intermediary complexes and Stable E-P rings | Involve in T-cell leukemia formation | (97) |
|
KSHV-infected primary
effusion lymphoma |
TRExBCBL1 cell | MYC SE | MYC eRNA (e486, e507, e530) |
MYC | Alteration of host epigenome status | Promote viral lysis and replication | (153) |
| Chronic granulocytic leukemi | Leukemia cell | Hmrhl enhancer | Hmrhl eRNA | phkb | No | Regulate positively phkb genes | (154) |
| MLL rearranged leukemia | MLL leukemia cells | Enhancer | SEELA eRNA | SERINC2 | Promotion of histone recognition | Regulate tumor metabolism | (155) |
| Chronic myeloid leukemia | Leukemia cell | VEGFA157 enhancer | VEGFA157 eRNA | VEGFA | Selective splicing of target genes | Promote CML pathology | (156) |
| Gastric cancer | Gastric epithelium | BIRC3 enhancer | BIRC3 eRNA | BIRC3 cIAP2 |
Inhibition of caspase-3 activation | Enhance apoptosis resistance in gastric epithelial cells | (92, 94) |
| Colorectal cancer | CRC cell | Carcinogenic SE | eRNA | IL-20RA | Elevated expression of cell proliferation and immune evasion genes | Modulate carcinogenic and immune pathways | (157) |